ConductScience.org, home

Paper38263239

The HIV-1 gag p6: a promising target for therapeutic intervention.

Chen X and 1 other. Retrovirology, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. The HIV-1 gag p6: a promising target for therapeutic intervention. Papers, record 38263239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38263239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The HIV-1 gag p6: a promising target for therapeutic intervention.
PubMed
Journal
Retrovirology
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.04, provisional
iCite
Revised in PubMed
2024-10-29
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen XXiaowei
2Wang XXiao

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV-1Major topic
Humans
Anti-Retroviral Agents
Biological Transport
Cell Membrane
Endosomal Sorting Complexes Required for Transport

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No NumberBinzhou Medical UniversityPubMed
No NumberBinzhou Medical UniversityPubMed

Source PubMed

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12014240Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/2014240PubMed
234106747HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.J Virol2021https://conductscience.org/library/papers/34106747PubMed
327120610Glutamic Acid Residues in HIV-1 p6 Regulate Virus Budding and Membrane Association of Gag.Viruses2016https://conductscience.org/library/papers/27120610PubMed
423174350HIV-1 p6 - a structured to flexible multifunctional membrane-interacting protein.Biochim Biophys Acta2013https://conductscience.org/library/papers/23174350PubMed
521482733The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 Gag regulates its ubiquitination and MHC class I antigen presentation.J Immunol2011https://conductscience.org/library/papers/21482733PubMed
621394083Dynamics of ESCRT protein recruitment during retroviral assembly.Nat Cell Biol2011https://conductscience.org/library/papers/21394083PubMed
720305637Molecular mechanism of multivesicular body biogenesis by ESCRT complexes.Nature2010https://conductscience.org/library/papers/20305637PubMed
87884883Progression to AIDS in the absence of a gene for vpr or vpx.J Virol1995https://conductscience.org/library/papers/7884883PubMed
919923179HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag.J Virol2010https://conductscience.org/library/papers/19923179PubMed
1019883084The role of membranes in the organization of HIV-1 Gag p6 and Vpr: p6 shows high affinity for membrane bilayers which substantially increases the interaction between p6 and Vpr.J Med Chem2009https://conductscience.org/library/papers/19883084PubMed
118523520A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr.J Virol1996https://conductscience.org/library/papers/8523520PubMed
127707498The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.J Virol1995https://conductscience.org/library/papers/7707498PubMed
1324412650Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing.Cell2014https://conductscience.org/library/papers/24412650PubMed
1411595185Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.Cell2001https://conductscience.org/library/papers/11595185PubMed
1534353956Maturation of the matrix and viral membrane of HIV-1.Science2021https://conductscience.org/library/papers/34353956PubMed
1624843179Cryo-electron microscopy of tubular arrays of HIV-1 Gag resolves structures essential for immature virus assembly.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24843179PubMed
1733863979CryoET structures of immature HIV Gag reveal six-helix bundle.Commun Biol2021https://conductscience.org/library/papers/33863979PubMed
1815363109Identification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virion.Retrovirology2004https://conductscience.org/library/papers/15363109PubMed
199525617Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus.J Virol1998https://conductscience.org/library/papers/9525617PubMed
2010085158Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor.J Biol Chem1999https://conductscience.org/library/papers/10085158PubMed

See all 46 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42926599HIV-1 Assembly is Assisted by IRSp53 Through an Interaction that Extends Gag Conformation.bioRxiv2026https://conductscience.org/library/papers/42926599PubMed
41453210Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication.FEMS Microbiol Rev2026https://conductscience.org/library/papers/41453210PubMed
41068455Nuclear pore passage of the HIV capsid is driven by its unusual surface amino acid composition.Nat Struct Mol Biol2025https://conductscience.org/library/papers/41068455PubMed
40838881Negative interplay between HIV-1 Gag and amyloid precursor protein centers around competition for VPS4A and TSG101.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40838881PubMed
39793042Mechanism-guided engineering of a minimal biological particle for genome editing.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/39793042PubMed
39772271Viral Oncogenesis: Synergistic Role of Genome Integration and Persistence.Viruses2024https://conductscience.org/library/papers/39772271PubMed
39728994Understanding Post-Translational Modifications in Porcine Reproductive and Respiratory Syndrome Virus Infection.Vet Sci2024https://conductscience.org/library/papers/39728994PubMed
39286001Computational identification and analysis of CNP0269688 as a natural product inhibitor disrupting the interaction between the HIV matrix domain and tRNA.Front Chem2024https://conductscience.org/library/papers/39286001PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38263239

GET https://conductscience.org/api/papers/v1/38263239/references?page=2